News Announcement

Aspira Pathlab & Diagnostics: Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation &Disclosure Requirements) Regulations 2015 For The Half Year Ended September 30 2019

Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligation &Disclosure Requirements) Regulations 2015 we hereby submit the disclosure on Related Party Transactions on standalone basis drawn in accordance with applicable accounting standards for the half-year ended September 30 2019.
Kindly take the above information on record and acknowledge the receipt.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.